{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T11:54:54Z","timestamp":1781783694053,"version":"3.54.5"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL113382"],"award-info":[{"award-number":["R01HL113382"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30DK089507"],"award-info":[{"award-number":["P30DK089507"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1HL119073"],"award-info":[{"award-number":["UM1HL119073"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI101307"],"award-info":[{"award-number":["R01AI101307"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1 TR005294"],"award-info":[{"award-number":["UM1 TR005294"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jcf.2025.12.003","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T12:45:25Z","timestamp":1765975525000},"page":"218-224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating the association of antibiotic spectrum and treatment responses of cystic fibrosis pulmonary exacerbations"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3731-9675","authenticated-orcid":false,"given":"Ranjani","family":"Somayaji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0382-6858","authenticated-orcid":false,"given":"Jonathan D.","family":"Cogen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5727-8164","authenticated-orcid":false,"given":"Donald","family":"VanDevanter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J","family":"LiPuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie E.","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6265-6249","authenticated-orcid":false,"given":"Don B","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3076-3186","authenticated-orcid":false,"given":"Jeffrey S","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1856-6841","authenticated-orcid":false,"given":"Matthew P.","family":"Kronman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher H.","family":"Goss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick A.","family":"Flume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonya L.","family":"Heltshe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jcf.2025.12.003_bib0001","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1651-2227.1983.tb09789.x","article-title":"Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection","volume":"72","author":"Szaff","year":"1983","journal-title":"Acta Paediatr Scand"},{"key":"10.1016\/j.jcf.2025.12.003_bib0002","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1164\/ajrccm\/141.4_Pt_1.914","article-title":"Reduction of sputum Pseudomonas aeruginosa density by antibioitics improves lung function in cystic fibrosis more than do bronchodilators and chest physiotherapy alone","volume":"141","author":"Regelmann","year":"1990","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jcf.2025.12.003_bib0003","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/ppul.23147","article-title":"Antibiotic treatment of signs and symptoms of pulmonary exacerbations: a comparison by care site","volume":"50","author":"Schechter","year":"2015","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2025.12.003_bib0004","doi-asserted-by":"crossref","first-page":"e531","DOI":"10.1542\/peds.2006-1414","article-title":"Infant care patterns at epidemilogic study of cystic fibrosis sistes that achieve superior childhood lung function","volume":"119","author":"Padman","year":"2007","journal-title":"Pediatr"},{"issue":"9","key":"10.1016\/j.jcf.2025.12.003_bib0005","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1164\/rccm.200812-1845PP","article-title":"Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations","volume":"180","author":"Flume","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.jcf.2025.12.003_bib0006","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jcf.2018.02.006","article-title":"ECFS best practice guidelines: the 2018 revision","volume":"17","author":"Castellani","year":"2019","journal-title":"J Cyst Fibros: Off J Eur Cyst Fibros Soc"},{"issue":"11","key":"10.1016\/j.jcf.2025.12.003_bib0007","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.202102-0461OC","article-title":"A randomized clinical trial of antimicrobial duration for cystic fibrosis pulmonary exacerbation treatment","volume":"204","author":"Goss","year":"2021","journal-title":"Am J Resp Crit Care Med"},{"issue":"4","key":"10.1016\/j.jcf.2025.12.003_bib0008","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jcf.2021.11.009","article-title":"Association of site of treatment with clinical outcomes following intravenous antimicrobial treatment of a pulmonary exacerbation","volume":"21","author":"Sanders","year":"2021","journal-title":"J Cyst Fibros: Off J Eur Cyst Fibros Soc"},{"issue":"5","key":"10.1016\/j.jcf.2025.12.003_bib0009","doi-asserted-by":"crossref","DOI":"10.1513\/AnnalsATS.202308-673OC","article-title":"Adjunctive systemic corticosteroids for pulmonary exacerbations of cystic fibrosis","volume":"21","author":"McElvaney","year":"2023","journal-title":"Ann ATS"},{"issue":"6","key":"10.1016\/j.jcf.2025.12.003_bib0010","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02278-2023","article-title":"A randomised trial of oral prednisone for cystic fibrosis pulmonary exacerbation treatment","volume":"63","author":"Waters","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2025.12.003_bib0011","article-title":"Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in cystic fibrosis","author":"Wagener","year":"2012","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"10.1016\/j.jcf.2025.12.003_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.2016-2642","article-title":"Characterization of inpatient cystic fibrosis pulmonary exacerbations","volume":"139","author":"Cogen","year":"2017","journal-title":"Pediatr"},{"key":"10.1016\/j.jcf.2025.12.003_bib0013","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jcf.2017.04.003","article-title":"on behalf of the STOP investigators. Standardized treatment of pulmonary exacerbations (STOP) study: physician treatment practices and outcomes for individuals with cystic fibrosis with pulmonary exacerbations","volume":"16","author":"West","year":"2017","journal-title":"J Cyst Fibros: Off J Eur Cyst Fibros Soc"},{"issue":"10325","key":"10.1016\/j.jcf.2025.12.003_bib0014","first-page":"629","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"389","year":"2022","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.jcf.2025.12.003_bib0016","first-page":"20","article-title":"The importance of an antimicrobial stewardship program","volume":"32","author":"Baroudi","year":"2015","journal-title":"Fed Pr"},{"issue":"1","key":"10.1016\/j.jcf.2025.12.003_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijantimicag.2004.09.001","article-title":"A multidisciplinary approach to antimicrobial stewardship: evolution into the 21st century","volume":"25","author":"Paskovaty","year":"2005","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"10.1016\/j.jcf.2025.12.003_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2020.02.012","article-title":"Finding the relevance of antimicrobial stewardship for cystic fibrosis","volume":"19","author":"Cogen","year":"2020","journal-title":"J Cyst Fibros: Off J Eur Cyst Fibros Soc"},{"issue":"7","key":"10.1016\/j.jcf.2025.12.003_bib0019","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1513\/AnnalsATS.201401-034OI","article-title":"Is there a role for antimicrobial stewardship in cystic fibrosis?","volume":"11","author":"Waters","year":"2014","journal-title":"Ann ATS"},{"key":"10.1016\/j.jcf.2025.12.003_bib0020","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s40506-018-0157-9","article-title":"Antimicrobial stewardship in the treatment of infections among patients with cystic fibrosis","volume":"10","author":"Bhowmick","year":"2018","journal-title":"Curr Treat Opt Infect Dis"},{"issue":"8","key":"10.1016\/j.jcf.2025.12.003_bib0021","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1017\/ice.2017.94","article-title":"Development and application of an antibiotic spectrum index for benchmarking antibiotic selection patterns across hospitals","volume":"38","author":"Gerber","year":"2017","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"2","key":"10.1016\/j.jcf.2025.12.003_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.106710","article-title":"Antibiotic spectrum index as an antimicrobial stewardship tool in paediatric intensive care settings","volume":"61","author":"Zombori","year":"2023","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"10.1016\/j.jcf.2025.12.003_bib0023","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.jcf.2024.03.004","article-title":"Creation of a CF-specific antibiotic spectrum index (ASI) as an antimicrobial stewardship initiative","volume":"23","author":"Cogen","year":"2024","journal-title":"J Cyst Fibros: Off J Eur Cyst Fibros Soc"},{"key":"10.1016\/j.jcf.2025.12.003_bib0024","first-page":"76","article-title":"A practical guide to propensity score analysis for applied clnical research","volume":"98","author":"Lee","year":"2017","journal-title":"Behav ResTher"},{"key":"10.1016\/j.jcf.2025.12.003_bib0025","series-title":"R: a language and environment for statistical computing","year":"2020"},{"issue":"1","key":"10.1016\/j.jcf.2025.12.003_bib0026","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/EDE.0000000000000564","article-title":"Biases in randomized trials: a conversation between trialists and epidemiologists","volume":"28","author":"Mansournia","year":"2018","journal-title":"Epidemiol"},{"issue":"3","key":"10.1016\/j.jcf.2025.12.003_bib0027","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jcf.2019.10.006","article-title":"Antimicrobial resistance in cystic fibrosis: a Delphi approach to defining best practices","volume":"19","author":"Zemanick","year":"2020","journal-title":"J cyst fibros: off j Eur Cyst Fibros Soc"},{"issue":"4","key":"10.1016\/j.jcf.2025.12.003_bib0028","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jcf.2023.02.001","article-title":"Polymicrobial infections and antibiotic treatment patterns for cystic fibrosis pulmonary exacerbations","volume":"22","author":"Faino","year":"2023","journal-title":"J cyst fibros: off j Eur Cyst Fibros Soc"},{"issue":"1","key":"10.1016\/j.jcf.2025.12.003_bib0029","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1378\/chest.123.1.20","article-title":"Factors influencing outcomes in cystic fibrosis: a center-based analysis","volume":"123","author":"Johnson","year":"2003","journal-title":"Chest"},{"issue":"S2","key":"10.1016\/j.jcf.2025.12.003_bib0030","first-page":"58","article-title":"Antimicrobial susceptibility testing (AST) and associated clinical outcomes in individuals with cystic fibrosis: a systematic review","volume":"53","author":"Somayaji","year":"2019","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"10.1016\/j.jcf.2025.12.003_bib0031","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/resp.12714","article-title":"Pseudomonas aeruginosa antibiotic resistance in Australian cystic fibrosis centres","volume":"21","author":"Smith","year":"2016","journal-title":"Respirology"},{"issue":"4","key":"10.1016\/j.jcf.2025.12.003_bib0032","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0022-3476(99)70197-6","article-title":"Comparison of a beta-latam alone versus beta-lactam and an aminoglycoside for pulmonary exacerbation in cystic fibrosis","volume":"134","author":"Smith","year":"1999","journal-title":"J Pediatr"},{"issue":"11","key":"10.1016\/j.jcf.2025.12.003_bib0033","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1136\/thx.52.11.987","article-title":"Intravenous colistin sulphomethate in acute respiratory exacerbations in adult patients with cystic fibrosis","volume":"52","author":"Conway","year":"1997","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.jcf.2025.12.003_bib0034","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.jcf.2022.04.006","article-title":"Antipseudomonal treatment decisions during CF exacerbation management","volume":"21","author":"VanDevanter","year":"2022","journal-title":"J Cyst Fibros: Off J Eur Cyst Fibros Soc"},{"issue":"11","key":"10.1016\/j.jcf.2025.12.003_bib0035","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1097\/INF.0000000000003211","article-title":"Impact of anaerobic antibacterial spectrum on cystic fibrosis airway microbiome diversity and pulmonary function","volume":"40","author":"Bozzella","year":"2021","journal-title":"Pediatr Infect Dis"},{"issue":"6","key":"10.1016\/j.jcf.2025.12.003_bib0036","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1097\/CCM.0000000000003119","article-title":"The surviving sepsis campaign bundle: 2018 update","volume":"46","author":"Levy","year":"2018","journal-title":"Crit Care Med"},{"issue":"5","key":"10.1016\/j.jcf.2025.12.003_bib0037","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/ppul.1060","article-title":"Efficacy of once-daily tobramycin monotherapy for acute pulmonary exacerbations of cystic fibrosis: a preliminary study","volume":"31","author":"Master","year":"2001","journal-title":"Pediatr Pulmonol"},{"issue":"7","key":"10.1016\/j.jcf.2025.12.003_bib0038","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/00006454-198707000-00006","article-title":"Ceftazidime monotherapy vs. combined therapy in Pseudomonas pulmonary infections in cystic fibrosis","volume":"6","author":"Padoan","year":"1987","journal-title":"Pediatr Infect Dis"},{"issue":"9","key":"10.1016\/j.jcf.2025.12.003_bib0039","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1164\/rccm.201610-2172OC","article-title":"Home monitoring of patients with cystic fibrosis to identify and treat acute pulmonary exacerbations. eICE study results","volume":"196","author":"Lechtzin","year":"2017","journal-title":"Am J Resp Crit Care Med"},{"issue":"3","key":"10.1016\/j.jcf.2025.12.003_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.108835","article-title":"Airway inflammation accelerates pulmonary exacerbations in cystic fibrosis","volume":"27","author":"Liou","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.jcf.2025.12.003_bib0041","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1445-5994.1999.tb01583.x","article-title":"Are antipseudomonal antibiotics really beneficial in acute respiratory exacerbations of cystic fibrosis","volume":"29","author":"Wolter","year":"1999","journal-title":"Aust N Z J Med"},{"issue":"4","key":"10.1016\/j.jcf.2025.12.003_bib0042","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1513\/AnnalsATS.202306-576OC","article-title":"Prevalence and clinical impact of respiratory viral infections from the STOP2 study of cystic fibrosis pulmonary exacerbations","volume":"21","author":"Thornton","year":"2024","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jcf.2025.12.003_bib0043","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1017\/ice.2024.137","article-title":"Antibiotic spectrum covrage scoring as a potential metric evaluating the antimicrobial stewardship team activity: a single-center study","volume":"45","author":"Oda","year":"2024","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"4","key":"10.1016\/j.jcf.2025.12.003_bib0044","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/cid\/ciab1034","article-title":"Days of antibiotic spectrum coverage: a novel metric for inpatient antibiotic consumption","volume":"75","author":"Kakiuchi","year":"2022","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199325025330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199325025330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T11:38:08Z","timestamp":1781782688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199325025330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1569199325025330"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2025.12.003","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the association of antibiotic spectrum and treatment responses of cystic fibrosis pulmonary exacerbations","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2025.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}